Technicals Say Sonnet BioTherapeutics Holdings Inc. (SONN) Is Worth Holding
At the last check on Thursday, Sonnet BioTherapeutics Holdings Inc.’s (NASDAQ:SONN) stock was down -$0.07, moving down -23.68 percent to $0.21. The average number of shares traded per day over the past five days has been 1,201,910 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0670 fall in […]
Sonnet BioTherapeutics Holdings Inc. (SONN): Keep paying attention to its insider activity
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) saw a downside of -8.03% to close Tuesday at $0.28 after subtracting -$0.02 on the day. The 5-day average trading volume is 7,278,260 shares of the company’s common stock. It has gained $0.4585 in the past week and touched a new high 1 time within the past 5 days. An […]
Sonnet BioTherapeutics Holdings Inc. (SONN) Price Targets: What Are They?
The stock of Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) increased by $0.07 on Wednesday to $0.40, up 22.13 percent. The last five days have seen an average of 4,109,612 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$0.7093. The average number of shares traded over […]
Sonnet BioTherapeutics Holdings Inc. (SONN) touched a new high 3 times within the past 5 days.
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) saw a downside of -8.24% to $0.33 after subtracting -$0.03 on Tuesday. The 5-day average trading volume is 935,526 shares of the company’s common stock. It has gained $0.3950 in the past week and touched a new high 3 times within the past 5 days. An average of 975,006 shares […]
Sonnet BioTherapeutics Holdings Inc. (SONN) Is A Stock You Should Watch
At the last check on Friday, Sonnet BioTherapeutics Holdings Inc.’s (NASDAQ:SONN) stock was up $0.03, moving up 9.17 percent to $0.38. The average number of shares traded per day over the past five days has been 638,632 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0298 gain in […]
